This proprietary Nanotech has been heavily researched and published in various HC industries/journals and we have a Phase 2A IRB Dbl blinded, randomized HCT showing that (unlike all other forms of ionic silver) there is no risk of metabolization or Argyriosis
Because of its defined amino acid structure and reproducible synthesis profile, it is often included in controlled laboratory research evaluating peptide behavior, formulation characteristics, and analytical peptide performance
Dec 30, 2025 The question "how long does GHK-Cu last" has multiple answers depending on what you're actually asking
Vendors that publish lot-matched CoAs and accept third-party analytical re-testing (Janoshik Analytical, Anabolic Lab and similar independent peptide labs) are the practical gold standard in the research-peptide space
Therefore, the purpose of the present study is to mainly investigate the effect of Sirt1 on oxygen-glucose deprivation/reoxygenation (OGD/R)-treated N9 microglia following treatment with the Sirt1 agonists resveratrol and SRT1720 and the Sirt1 antagonist sirtinol
US patent 0337024, Allison Coffin, Joseph Harding, Leen Kawas, Phillip Uribe, "Novel Lead Compound for Otoprotection: Targeting HGF Signaling with Dihexa", issued 2015-11-26 "Dihexa" (PDF)
